Search - tctmd.com

Displaying 1 - 20 of 96

Sort: Relevancy | Date

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

May 09, 2025

STS Experts Tackle Need For Women-Only Trials in Surgery

News Conference News STS 2025

STS Experts Tackle Need For Women-Only Trials in Surgery

Yael L. Maxwell

January 29, 2025

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow

News Conference News EACTS 2024

‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow

Yael L. Maxwell

October 17, 2024

Little Pre- and Postmarket Testing for Most Recalled CV Devices

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

Statins Are Cost-effective in the Elderly

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

FDA to Add New Diversity Requirements for Certain Clinical Studies

News Daily News

FDA to Add New Diversity Requirements for Certain Clinical Studies

July 15, 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

May 06, 2024

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

News Daily News

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Yael L. Maxwell

March 07, 2024

Mechanism’s Mojo ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

AI-Based System Boosts Quality of Stroke Care and Reduces Events

News Conference News ISC 2024

AI-Based System Boosts Quality of Stroke Care and Reduces Events

February 16, 2024

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

Women and Minorities Underrepresented in Heart Valve Trials

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

July 27, 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

May 26, 2023

First-Ever Cardiac Surgery Trial in Women Poised to Launch: ROMA-Women

News Daily News

First-Ever Cardiac Surgery Trial in Women Poised to Launch: ROMA-Women

April 07, 2023

ChatGPT et al? Not So Fast, Say Journal Editors

News Features

ChatGPT et al? Not So Fast, Say Journal Editors

Yael L. Maxwell

April 05, 2023

The Promise of AI for Improving Health Equity in Heart Failure

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

April 04, 2023

TCTMD’s Top 10 Most Popular Stories for January 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2023

February 01, 2023

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

News Conference News ISET 2023

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

January 25, 2023

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

News Daily News

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Yael L. Maxwell

December 12, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.